Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Botanix Pharmaceuticals.
RELATED STOCKHEAD STORIES
News
10 at 10: These 10 ASX stocks are looking primed for the rebound this morning
Health & Biotech
Health: Neuren gets extra FDA push for its treatment for rare Rett disease
Health & Biotech
Australia is a leader in cannabis biotechs – here are three stocks that could be poised for growth
Health & Biotech
Here’s how to pick a successful drug out of the 99pc of failures
Health & Biotech
WA biotechs are booming; now government wants to make the state a life sciences hub
Health & Biotech
NT pot scripts stand at 1 as industry begs govt to act on patient access
Health & Biotech
The US legal pot market is massive and confusing: report
News
Trading Places: Here are this week’s substantial holder movements
News
Short and Caught: The ASX stocks investors are shorting right now
Health & Biotech
Biotech: Pesky pimple-like rosacea to get Botanix’s Permetrex treatment in early study
Health & Biotech
Cannabis: Elixinol cops $2.2m profit hit on Japanese divestment
News
Short and Caught: The ASX stocks investors are shorting right now
Health & Biotech
Weed Week: Wait till cannabis is legalised federally in the US – big pharma are already dreading it
Health & Biotech
Health: Botanix buddy set to benefit after DEA admits their synthetic CBD is probably ok
News
Short and Caught: The ASX stocks investors are shorting right now
Health & Biotech
These are the 22 small cap biotechs closest to bringing a drug to market
News